| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -44.87M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AVIR returned +45.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +48.7% |
| 1 year | +45.1% |
| 5 years | -82.1% |
| All-time high | $75.36 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AVIR would be worth today ›No. Atea Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Atea Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol AVIR.
Atea Pharmaceuticals, Inc. is part of the Healthcare sector.
Atea Pharmaceuticals, Inc. has a market cap of 425.89M USD, based on the latest quote.
Atea Pharmaceuticals, Inc. is scheduled to report earnings on Nov 11, 2026.
